Careers
Dr. Namitha Kumar's Profile
MA, PhD
Namitha A Kumar has a PhD in psychology from the National Institute of Advanced Studies (NIAS) focusing on the cognitive aspects of disability. She works in the field of rare, genetic disorders and currently, develops all the medical content for the Open Platform for Rare Diseases (OPFORD).
Written / Edited / Medically Reviewed
Liquid Biopsies Enable Better Outcomes for Cancers
Liquid biopsies enable close monitoring of cancers in a minimally non-invasive method. Also, can detect, characterize, and monitor cancers much earlier than conventional methods. Liquid biopsies could soon become a routine test for preventive cancer screening.
Puberty
Puberty is a stage of biological transition from a child to adulthood. This is the time when the body undergoes a metabolic shift into adulthood.
CRISPR Gene Editing can Stop Progression of Triple-negative Breast Cancer
CRISPR gene editing technique can help stop the progression of triple-negative breast cancer. A new CRISPR nanotherapeutic discovered knocks out a breast cancer oncogene, called Lipocalin 2 (Lcn2) in triple-negative breast cancer.
Genes Underscore 5 Psychiatric Disorders
Doctors have discovered that a common set of genes in the brain are the underlying cause of five psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder (MDD), autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD).
Combination of Three Gene Mutations Can Result in Deadly Heart Disease
Human heart disease can be caused by rare, hereditary heterozygous mutations of three genes, reveals a new study. Genetic sequencing was used to prove that cardiac mutations inherited from both father and mother caused heart disease in siblings.
